Guest guest Posted March 3, 2008 Report Share Posted March 3, 2008 I see that " safety " is not among the top ten concerns of vaccine development. But shelf life and putting in more aluminum is! http://www.iirusa.com/vaccines/eventhome/39154.xml What Are the Top Ten Challenges Cited By Scientists in Vaccines Development? -Improving Compliance Through Better Understanding of Regulatory Requirements -Formulating More Thermostable Vaccines -Defining and Implementing a Development Plan Leading To a Commercially Viable Cancer Vaccine -Utilizing Forced Degradation and Accelerated Study Practices When Developing Vaccines -Improving Stability and Robustness When Developing Influenza Vaccines -Taping Into Methods to Advance Vaccine Stability Testing to Minimize -Development Changes -***Using Aluminum-Containing Adjuvants Effectively For Improved Formulation and Stability*** -Identifing and Solving Potential Adjuvant-Antigen Formulation Issues -Addressing the regulatory issues arising from incorporating a new adjuvant in your vaccine -Using Innovative Vaccine Delivery Techniques and Predict Their Impact on Formulation and Stability Studies Quote Link to comment Share on other sites More sharing options...
Guest guest Posted March 10, 2008 Report Share Posted March 10, 2008 I just saw an ad for this when looking at the PHARMA campaign contributions from October. Eww is right. " faster commercialization " ? That couldn't be scarier. http://www.pharmalot.com/2008/01/big-pharma-and-its-presidential-bets/ Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.